We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
(-4.4%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$41.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.6M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$29.6M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.3M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$46M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$45.2M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$41.1M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$28.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.86% |
| 2 | Financials | 4.76% |
| 3 | Consumer Discretionary | 4.5% |
| 4 | Healthcare | 4.18% |
| 5 | Consumer Staples | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Nuveen ESG International Developed Markets Equity ETF
NUDM
$728M
| $13.7M | 0.08% |
613,697
-39,875
| -6% | -$997K |
|
252
Pacer Trendpilot 100 ETF
PTNQ
$1.26B
| $13.6M | 0.08% |
276,389
+23,920
| +9% | +$1.25M |
|
253
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
| $13.4M | 0.08% |
101,904
-9,376
| -8% | -$1.31M |
|
254
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $13.4M | 0.08% |
139,083
+20,486
| +17% | +$2.19M |
|
255
iShares MSCI Intl Quality Factor ETF
IQLT
$14.2B
| $13.4M | 0.08% |
480,851
+78,591
| +20% | +$2.43M |
|
256
Northrop Grumman
NOC
$82.2B
| $13.4M | 0.08% |
28,390
+1,197
| +4% | +$570K |
|
257
Morgan Stanley
MS
$342B
| $13.3M | 0.08% |
168,430
-1,020
| -0.6% | -$86K |
|
258
BP
BP
$111B
| $13.1M | 0.07% |
459,066
-211
| -0% | -$6.28K |
|
259
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.6B
| $13M | 0.07% |
257,037
+29,426
| +13% | +$1.61M |
|
260
Berkshire Hathaway Class A
BRK.A
$1.09T
| $13M | 0.07% |
32
| – | – |
|
261
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.1B
| $13M | 0.07% |
265,154
+8,415
| +3% | +$458K |
|
262
Texas Instruments
TXN
$254B
| $13M | 0.07% |
83,790
-1,731
| -2% | -$290K |
|
263
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $12.9M | 0.07% |
571,144
+3,970
| +0.7% | +$94.5K |
|
264
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.23B
| $12.9M | 0.07% |
+201,011
| New | +$14.4M |
|
265
iShares US Healthcare ETF
IYH
$3.78B
| $12.9M | 0.07% |
254,715
+48,230
| +23% | +$2.61M |
|
266
Danaher
DHR
$146B
| $12.9M | 0.07% |
56,269
+1,568
| +3% | +$384K |
|
267
Occidental Petroleum
OXY
$58.6B
| $12.8M | 0.07% |
209,096
+67,125
| +47% | +$4.3M |
|
268
Blackrock
BLK
$179B
| $12.8M | 0.07% |
23,257
-3,223
| -12% | -$2.11M |
|
269
General Dynamics
GD
$107B
| $12.8M | 0.07% |
60,306
+5,784
| +11% | +$1.31M |
|
|
BSCM
270
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $12.7M | 0.07% |
601,259
+397,365
| +195% | +$8.43M |
|
271
Philip Morris
PM
$290B
| $12.6M | 0.07% |
152,154
-1,576
| -1% | -$150K |
|
272
iShares US Aerospace & Defense ETF
ITA
$15B
| $12.5M | 0.07% |
136,578
+12,361
| +10% | +$1.25M |
|
273
Medtronic
MDT
$116B
| $12.4M | 0.07% |
154,164
+5,282
| +4% | +$475K |
|
274
First Trust US Equity Opportunities ETF
FPX
$1.53B
| $12.4M | 0.07% |
152,738
-4,320
| -3% | -$379K |
|
275
Kinder Morgan
KMI
$70.8B
| $12.3M | 0.07% |
742,110
+92,536
| +14% | +$1.64M |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
- Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
- Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
- Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
- Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
- Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.